Kancera AB operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Kancera AB with three other
pharmaceutical manufacturers in Europe:
Infant Bacterial Therapeutics AB
sales of 162,000.00 Swedish Kronor [US$18,417.78 ]
Vicore Pharma Holding AB
(852,000.00 Swedish Kronor [US$96,863.88 ]
Index Pharmaceuticals Holding Ab
(176,000.00 Swedish Kronor [US$20,009.44 ]
Kancera AB reported sales of SEK 308,000.00 (US$35.02 thousand)
December of 2016.
increase of 9.2%
versus 2015, when the company's sales were SEK 282,000.00 .
Despite this increase, sales are still
below the level achieved in 2014, when Kancera AB
reported sales of SEK 470,000.00 .